U.S., Nov. 25 -- ClinicalTrials.gov registry received information related to the study (NCT07245953) titled 'A Clinical Study of HT-101 and HT-102 in Patients With Chronic Hepatitis B Virus Infection' on Nov. 17.
Brief Summary: This study is A multicenter, randomized, double-blind, placebo-controlled phase 2 clinical study to evaluate the efficacy and safety of HT-101 injection combined with HT-102 injection in patients with chronic hepatitis B. It consists of two phases: the main trial and the extension period. The main trial phase aims to explore the efficacy of different courses of HT-101 injection combined with HT-102 injection in treating patients with chronic hepatitis B and evaluate the optimal treatment strategy. The extension peri...